Role of time in target range in blood pressure management for preventing renal decline in type 2 diabetes.

CommentOn

Hypertens Res. 2025 May;48(5):1787-1798. doi: 10.1038/s41440-025-02173-4.

COI Statement

Compliance with ethical standards. Conflict of interest: Conflict of interest KK received personal fees for lectures from Daiichi Sankyo and Novartis Pharma.

References:

• O’Seaghdha CM, Perkovic V, Lam TH, McGinn S, Barzi F, Gu DF, et al. Blood pressure is a major risk factor for renal death: an analysis of 560 352 participants from the Asia-Pacific region. Hypertension. 2009;54:509–15.
• Lee JY, Park JT, Joo YS, Lee C, Yun HR, Yoo TH, et al. Association of blood pressure with the progression of CKD: findings from KNOW-CKD study. Am J Kidney Dis. 2021;78:236–45.
• Park CH, Kim HW, Joo YS, Park JT, Chang TI, Yoo TH, et al. Findings from the KNOW-CKD Study indicate that higher systolic blood pressure time in target range is associated with a lower risk of chronic kidney disease progression. Kidney Int. 2024;105:835–43.
• Cheng Y, Zhu XB, Xu YL, Zou J, Huang W, Tian J, et al. Time in target range of systolic blood pressure and eGFR slopein patients with type 2 diabetes. Hypertens Res. 2025. https://doi.org/10.1038/s41440-025-02173-4 .
• Bi Y, Li M, Liu Y, Li T, Lu J, Duan P, et al. Intensive blood-pressure control in patients with type 2 diabetes. N Engl J Med. 2025;392:1155–67.